...
首页> 外文期刊>Diagnostic pathology >Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas
【24h】

Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas

机译:B细胞淋巴瘤中Kappa和Lambda轻链mRNA原位杂交与流式细胞术和免疫组化的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Detection of B cell clonality is useful for assisting in the diagnosis of B cell lymphomas. Clonality assessment can be accomplished through evaluation of KAPPA and LAMBDA light chain expression. Currently, only slide based methods are available for the majority of patient biopsies and do not detect light chain protein or mRNA in many B-cell lymphomas. Herein we evaluated a new method, known as colorimetric in situ hybridization (CISH), with improved sensitivity and multiplexing capacity, for its usefulness in clonality detection in mature B cell malignancies. Methods The KAPPA and LAMBDA ISH was performed on a Ventana Benchmark XT utilizing two color chromogenetic detection. The probes comprised 2 haptenated riboprobes each approximately 500 base pairs long directed against the conserved regions of either KAPPA or LAMBDA mRNA. The dual colors consisted of silver deposition (black) for KAPPA light chain and a novel (pink) chromogen for LAMBDA light chain. Following optimization, CISH allowed visualization of mRNA in benign B cells in reactive tissues including germinal center, mantle zone, and post-germinal center cells. We then identified 79 cases of B cell lymphoma with formalin-fixed paraffin-embedded (FFPE) biopsies including: follicular (36 cases), mantle cell (6 cases), marginal zone (12 cases), lymphoplasmacytic (6 cases), small lymphocytic (4 cases), and diffuse large B cell (15 cases), which were selected on the basis of either prior flow cytometry or immunohistochemistry (IHC) results to serve as the predicate, "gold standard," comparator. Results 39/79 (49.4%) cases were classified as KAPPA and 29/79 (36.7%) as LAMBDA light chain restricted; while 9/79 (11.3%) cases were classified as indeterminate. Of the 70 cases with KAPPA or LAMBDA light chain restricted CISH, 69/70 (98.6%) were concordant with the reference method, while 1/70 (1.4%) was discordant. Conclusions Optimized CISH detected lower levels of mRNA than can be visualized with current slide based methods, making clonality assessment in FFPE biopsies possible for mature B cell neoplasms. In this preliminary study, CISH was highly accurate compared to flow cytometry or IHC. CISH offers the possibility of wider applicability of light chain ISH and is likely to become a useful diagnostic tool. Virtual Slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1430491067123856 webcite
机译:B细胞克隆性的背景检测可用于协助诊断B细胞淋巴瘤。克隆性评估可以通过评估KAPPA和LAMBDA轻链表达来完成。目前,只有基于玻片的方法可用于大多数患者活检,并且不能在许多B细胞淋巴瘤中检测到轻链蛋白或mRNA。在这里,我们评估了一种新方法,称为比色原位杂交(CISH),具有提高的灵敏度和多路复用能力,因为它可用于成熟B细胞恶性肿瘤的克隆性检测。方法使用两色显色检测法在Ventana Benchmark XT上进行KAPPA和LAMBDA ISH。探针包含2个半透明核糖核蛋白,每个核糖体长约500个碱基对,针对KAPPA或LAMBDA mRNA的保守区域。两种颜色包括用于KAPPA轻链的银沉积(黑色)和用于LAMBDA轻链的新型(粉红色)色原。经过优化后,CISH允许可视化反应组织(包括生发中心,套膜区和发芽后中心细胞)中良性B细胞中的mRNA。然后我们确定了79例福尔马林固定石蜡包埋(FFPE)活检的B细胞淋巴瘤,包括:滤泡性(36例),套细胞(6例),边缘区(12例),淋巴浆细胞性(6例),小淋巴细胞(4例)和弥漫性大B细胞(15例),它们是根据先前的流式细胞术或免疫组织化学(IHC)结果选择的,用作谓语“金标准”比较器。结果39/79(49.4%)例为KAPPA,29/29/79(36.7%)例为LAMBDA轻链受限; 9/79(11.3%)个案件被归类为不确定。在KAPPA或LAMBDA轻链限制性CISH的70例患者中,69/70(98.6%)与参考方法相符,而1/70(1.4%)与参考方法相符。结论优化的CISH检测到的mRNA水平低于目前基于幻灯片的方法所能观察到的水平,这使得FFPE活检中的克隆性评估可用于成熟B细胞肿瘤。在这项初步研究中,与流式细胞仪或IHC相比,CISH的准确性很高。 CISH为轻链ISH的广泛应用提供了可能性,并可能成为有用的诊断工具。虚拟幻灯片可以在此处找到本文的虚拟幻灯片:http://www.diagnosticpathology.diagnomx.eu/vs/1430491067123856网站

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号